T37.8X5 Category · further specificity required Adverse effect of other specified systemic anti-infectives and antiparasitics
ICD-10-CM T37.8X5 identifies “Adverse effect of other specified systemic anti-infectives and antiparasitics” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 19: Injury, poisoning and certain other consequences of external causes
Code-level instructions
No additional notes.
Inherited instructions
Chapters 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T37 · Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics
Excludes 13
Seventh character1
The appropriate 7th character is to be added to each code from category T37
A — initial encounter
D — subsequent encounter
S — sequela
T37.8 · Poisoning by, adverse effect of and underdosing of other specified systemic anti-infectives and antiparasitics
Inclusion terms1
Poisoning by, adverse effect of and underdosing of hydroxyquinoline derivatives
Excludes 11
antimalarial drugs (T37.2-)
More specific codes
T37.8X5AAdverse effect of other specified systemic anti-infectives and antiparasitics, initial encounterBillable / specificT37.8X5DAdverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounterBillable / specificT37.8X5SAdverse effect of other specified systemic anti-infectives and antiparasitics, sequelaBillable / specificOfficial index references
Official index references (80)
Akritoin (1)
- AkritoinDrugs and chemicals
Anti-infective NEC (2)
- Anti-infective NEC › arsenicalDrugs and chemicals
- Anti-infective NEC › heavy metals NECDrugs and chemicals
Antimony(compounds) (vapor) NEC (3)
- Antimony(compounds) (vapor) NEC › anti-infectivesDrugs and chemicals
- Antimony(compounds) (vapor) NEC › potassium(sodium) tartrateDrugs and chemicals
- Antimony(compounds) (vapor) NEC › tartratedDrugs and chemicals
Antiparasitic drug(systemic) (1)
- Antiparasitic drug(systemic) › specified NECDrugs and chemicals
Arsenic, arsenicals(compounds) (dust) (vapor) NEC (1)
- Arsenic, arsenicals(compounds) (dust) (vapor) NEC › anti-infectivesDrugs and chemicals
Arsphenamine(silver) (1)
- Arsphenamine(silver)Drugs and chemicals
Bismarsen (1)
- BismarsenDrugs and chemicals
Bismuth salts (3)
- Bismuth salts › anti-infectivesDrugs and chemicals
- Bismuth salts › subsalicylateDrugs and chemicals
- Bismuth salts › sulfarsphenamineDrugs and chemicals
Bithionol (1)
- BithionolDrugs and chemicals
Broxyquinoline (1)
- BroxyquinolineDrugs and chemicals
Chiniofon (1)
- ChiniofonDrugs and chemicals
Cinoxacin (1)
- CinoxacinDrugs and chemicals
Clioquinol (1)
- ClioquinolDrugs and chemicals
Croconazole (1)
- CroconazoleDrugs and chemicals
Dichlorhydroxyquinoline (1)
- DichlorhydroxyquinolineDrugs and chemicals
Diiodohydroxyquin (1)
- DiiodohydroxyquinDrugs and chemicals
Diiodohydroxyquinoline (1)
- DiiodohydroxyquinolineDrugs and chemicals
Diodoquin (1)
- DiodoquinDrugs and chemicals
Disinfectant (1)
- Disinfectant › intestinalDrugs and chemicals
Floraquin (1)
- FloraquinDrugs and chemicals
Fluconazole (1)
- FluconazoleDrugs and chemicals
Flucytosine (1)
- FlucytosineDrugs and chemicals
Flumequine (1)
- FlumequineDrugs and chemicals
Flunidazole (1)
- FlunidazoleDrugs and chemicals
Fluorocytosine (1)
- FluorocytosineDrugs and chemicals
Furazolidone (1)
- FurazolidoneDrugs and chemicals
Hexamine(mandelate) (1)
- Hexamine(mandelate)Drugs and chemicals
Hexetidine (1)
- HexetidineDrugs and chemicals
Hydroxychloroquine (1)
- HydroxychloroquineDrugs and chemicals
Hydroxyquinoline(derivatives) NEC (1)
- Hydroxyquinoline(derivatives) NECDrugs and chemicals
Iodobismitol (1)
- IodobismitolDrugs and chemicals
Iodochlorhydroxyquin (1)
- IodochlorhydroxyquinDrugs and chemicals
Iodochlorhydroxyquinoline (1)
- IodochlorhydroxyquinolineDrugs and chemicals
Iodoquinol (1)
- IodoquinolDrugs and chemicals
Itraconazole (1)
- ItraconazoleDrugs and chemicals
Lead(dust) (fumes) (vapor) NEC (1)
- Lead(dust) (fumes) (vapor) NEC › anti-infectivesDrugs and chemicals
Mandelic acid (1)
- Mandelic acidDrugs and chemicals
Mapharsen (1)
- MapharsenDrugs and chemicals
Meglumine (1)
- Meglumine › antimoniateDrugs and chemicals
Mercury, mercurial, mercuric, mercurous(compounds) (cyanide) (fumes) (nonmedicinal) (vapor) NEC (1)
Methenamine(mandelate) (1)
- Methenamine(mandelate)Drugs and chemicals
Methyl (1)
- Methyl › glucamine antimonateDrugs and chemicals
Metronidazole (1)
- MetronidazoleDrugs and chemicals
Nalidixic acid (1)
- Nalidixic acidDrugs and chemicals
Neoarsphenamine (1)
- NeoarsphenamineDrugs and chemicals
Neosalvarsan (1)
- NeosalvarsanDrugs and chemicals
Neosilversalvarsan (1)
- NeosilversalvarsanDrugs and chemicals
Nifuratel (1)
- NifuratelDrugs and chemicals
Nifurtoinol (1)
- NifurtoinolDrugs and chemicals
Nitrofurantoin (1)
- NitrofurantoinDrugs and chemicals
Nitroxoline (1)
- NitroxolineDrugs and chemicals
Oxolinic acid (1)
- Oxolinic acidDrugs and chemicals
Oxyquinoline(derivatives) (1)
- Oxyquinoline(derivatives)Drugs and chemicals
Pefloxacin (1)
- PefloxacinDrugs and chemicals
Pipemidic acid (1)
- Pipemidic acidDrugs and chemicals
Piromidic acid (1)
- Piromidic acidDrugs and chemicals
Potassium(salts) NEC (1)
- Potassium(salts) NEC › antimony ' tartrate'Drugs and chemicals
Quiniobine (1)
- QuiniobineDrugs and chemicals
Quinoline(derivatives) NEC (1)
- Quinoline(derivatives) NECDrugs and chemicals
Rosoxacin (1)
- RosoxacinDrugs and chemicals
Salvarsan 606(neosilver) (silver) (1)
- Salvarsan 606(neosilver) (silver)Drugs and chemicals
Silver (2)
- Silver › arsphenamineDrugs and chemicals
- Silver › salvarsanDrugs and chemicals
Sodium (1)
- Sodium › cacodylate(nonmedicinal) NEC › anti-infectiveDrugs and chemicals
Stovarsal (1)
- StovarsalDrugs and chemicals
Sulfarsphenamine (1)
- SulfarsphenamineDrugs and chemicals
Tartar emetic (1)
- Tartar emeticDrugs and chemicals
Tartrated antimony(anti-infective) (1)
- Tartrated antimony(anti-infective)Drugs and chemicals
Thiobismol (1)
- ThiobismolDrugs and chemicals
Thiocarbarsone (1)
- ThiocarbarsoneDrugs and chemicals
Tin(chloride) (dust) (oxide) NEC (1)
- Tin(chloride) (dust) (oxide) NEC › anti-infectivesDrugs and chemicals
Trimethoprim (1)
- TrimethoprimDrugs and chemicals
Urinary anti-infective (1)
- Urinary anti-infectiveDrugs and chemicals
Vioform (1)
- VioformDrugs and chemicals
Xibornol (1)
- XibornolDrugs and chemicals
History
Code history
Latest recorded change · FY2025 · 04-01
Effective from
- Inherited rules changed
Adverse effect of other specified systemic anti-infectives and antiparasitics
Category — select a more specific code
CDC/NCHS · FY2025 · 04-01All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | Inherited rules changed |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Inherited rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | Inherited rules changed |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.